510(k) Report

510(k) · Cleared

Recalled · 2008

Modification to Neurosensor Cerebral Blood Flow and Intracranial Pressure Monitoring System

K071505510(k) TraditionalCleared Aug 6, 200766-day reviewClass II21 CFR 882.1620Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Integra LifeSciences Corporation · GWM Device, Monitoring, Intracranial Pressure

Cleared on Aug 6, 2007 as substantially equivalent to K050720 (Integra Neurosciences, 2005) after a 66-day review. Its family tree reaches back 5 generations to 1988. It has been recalled once.

Decided
Aug 6, 2007
Review
66 days
Class
Class II
Product code
GWM
Recalls
1
Predicates
1

Its longest line of descent runs back 5 generations to K875179 (1988). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK875179 Modified Laserflo Blood Perfusion Monitor, BPM403ATsi, Inc. · 1988
  2. 4 generations backK951832 Laserflo Blood Perfusion Single Use Probes Models Sup-440, Supr-434…Vasamedics, LLC · 1996
  3. 3 generations backK961368 Trimflo Parenchymal Blood Flow Monitoring Probe KitVasamedics, LLC · 1996
  4. 2 generations backK013930 NeurosensorNovus Monitoring, Ltd. · 2002
  5. 1 generation backK050720 Neurosensor Cerebral Blood Flow and Intracranial Pressure Monitoring…Integra Neurosciences · 2005 · Recalled
  6. This deviceK071505 Modification to Neurosensor Cerebral Blood Flow and Intracranial…Integra LifeSciences Corporation · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K875179Modified Laserflo Blood Perfusion Monitor, BPM403ATsi, Inc.1988—
−4K951832Laserflo Blood Perfusion Single Use Probes Models Sup-440, Supr-434 Sup-433Vasamedics, LLC1996—
−3K961368Trimflo Parenchymal Blood Flow Monitoring Probe KitVasamedics, LLC1996—
−2K013930NeurosensorNovus Monitoring, Ltd.2002—
−1K050720Neurosensor Cerebral Blood Flow and Intracranial Pressure Monitoring…Integra Neurosciences20051
0 (this device)K071505Modification to Neurosensor Cerebral Blood Flow and Intracranial Pressure…Integra LifeSciences Corporation2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199110
199410
199810
FIG. 1 — Lineage of K071505, 1988–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWM device

  1. #1 K252241 Pressio 3 Multi-parameter Neuromonitoring Systemscore 13.0 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K050720Neurosensor Cerebral Blood Flow and Intracranial Pressure Monitoring Kit/System, Models…
Summary page 1
…substantially equivalent in function and intended use to the NeuroSensor® Cerebral Blood Flow and Intracranial Pressure Monitoring System previously cleared under 510(k) K050720 on 5/11/05. Testing was performed by Integra NeuroSciences, San Diego, CA, Integra NeuroSciences, Andover,UK and GemSoft, Inc in…
Integra Neurosciences20051

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 28, 2008Not classifiedZ-1191-2008Process designIncorrect pressure reading: Due to a manufacturing error, the ICP reading could be inaccurate to the extent that they exceed label claims. Specifically, the Insertion Error label claim of +/- 3mmHg could be exceeded by up to -3mmHg, that…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 5 companies; a new generation was cleared every 3.2 years on median.
  • 3 of the 9 ancestors have a recall of any class.

How does its category compare?

All GWM devices

GWM Device, Monitoring, Intracranial Pressure: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GWM

1in 2025

2007: 22008: 22009: 12010: 22011: 32012: 42013: 22014: 22016: 32017: 32018: 12019: 22020: 32021: 22024: 22025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWM

30in 2020

2011: 123 days median2012: 100 days median2016: 192 days median2017: 37 days median2020: 30 days median
2007high 192 (2016) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWM

3in 2025

2008: 12010: 92011: 62012: 12013: 122014: 22019: 12023: 1, 1 Class I2024: 4, 2 Class I2025: 3
2007high 12 (2013) · low 0 (2007)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · GWM

441in 2025

2007: 1262008: 1052009: 1172010: 1042011: 1842012: 1512013: 1202014: 3602015: 4862016: 4192017: 4452018: 3022019: 2602020: 2682021: 2112022: 4242023: 7442024: 6412025: 441
2007high 744 (2023) · low 104 (2010)2025

MAUDE reports naming product code GWM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—0126
20082—1105
20091—0117
20102—9104
201131236184
201241001151
20132—12120
20142—2360
20150—0486
201631920419
20173370445
20181—0302
20192—1260
20203300268
20212—0211
20220—0424
20230—1 (1)744
20242—4 (2)641
20251—3441
20261—0—

What is it indicated for?

NeuroSensor® Cerebral Blood Flow and Intracranial Pressure Monitoring System, is intended for use by a qualified clinician in monitoring cerebral blood flow in patients at risk of cerebral ischemia, and for the direct monitoring of intracranial pressure in intraparenchymal applications.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071505: Modification to Neurosensor Cerebral Blood Flow and Intracranial Pressure Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K071505

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026